Chemed Co. (NYSE:CHE) Shares Bought by CANADA LIFE ASSURANCE Co

CANADA LIFE ASSURANCE Co lifted its stake in shares of Chemed Co. (NYSE:CHE) by 1.7% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,325 shares of the company’s stock after purchasing an additional 169 shares during the period. CANADA LIFE ASSURANCE Co owned 0.07% of Chemed worth $6,629,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Raymond James & Associates raised its holdings in Chemed by 5.7% in the 4th quarter. Raymond James & Associates now owns 67,918 shares of the company’s stock valued at $39,715,000 after buying an additional 3,654 shares during the period. Raymond James Financial Services Advisors Inc. lifted its holdings in shares of Chemed by 55.8% in the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 2,308 shares of the company’s stock worth $1,349,000 after acquiring an additional 827 shares during the last quarter. Pacer Advisors Inc. boosted its position in shares of Chemed by 46.0% during the 4th quarter. Pacer Advisors Inc. now owns 2,665 shares of the company’s stock worth $1,558,000 after purchasing an additional 840 shares during the period. Chicago Capital LLC acquired a new stake in Chemed in the 4th quarter valued at approximately $1,170,000. Finally, Fenimore Asset Management Inc. raised its position in Chemed by 0.4% in the fourth quarter. Fenimore Asset Management Inc. now owns 27,202 shares of the company’s stock valued at $15,906,000 after purchasing an additional 115 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insider Transactions at Chemed

In related news, Director Patrick P. Grace sold 284 shares of the stock in a transaction on Wednesday, June 12th. The shares were sold at an average price of $540.98, for a total value of $153,638.32. Following the transaction, the director now directly owns 3,270 shares of the company’s stock, valued at approximately $1,769,004.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, Director Patrick P. Grace sold 284 shares of the firm’s stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $540.98, for a total transaction of $153,638.32. Following the transaction, the director now owns 3,270 shares in the company, valued at approximately $1,769,004.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Kevin J. Mcnamara sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, June 6th. The shares were sold at an average price of $544.17, for a total value of $816,255.00. Following the completion of the sale, the chief executive officer now owns 107,049 shares of the company’s stock, valued at approximately $58,252,854.33. The disclosure for this sale can be found here. In the last quarter, insiders sold 5,784 shares of company stock worth $3,240,053. 3.32% of the stock is currently owned by insiders.

Chemed Trading Up 1.5 %

Shares of NYSE:CHE opened at $549.27 on Friday. The company has a market cap of $8.32 billion, a PE ratio of 29.56, a P/E/G ratio of 2.23 and a beta of 0.43. The company’s 50 day moving average is $543.25 and its two-hundred day moving average is $583.12. Chemed Co. has a 52 week low of $492.84 and a 52 week high of $654.62.

Chemed (NYSE:CHE) last posted its quarterly earnings results on Wednesday, July 24th. The company reported $5.47 earnings per share for the quarter, missing analysts’ consensus estimates of $5.59 by ($0.12). The business had revenue of $595.88 million during the quarter, compared to analyst estimates of $599.20 million. Chemed had a net margin of 12.88% and a return on equity of 29.21%. The firm’s quarterly revenue was up 7.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $4.71 earnings per share. As a group, equities research analysts expect that Chemed Co. will post 21.54 EPS for the current year.

Chemed Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 18th. Shareholders of record on Thursday, May 30th were issued a dividend of $0.40 per share. The ex-dividend date of this dividend was Thursday, May 30th. This represents a $1.60 dividend on an annualized basis and a yield of 0.29%. Chemed’s payout ratio is currently 8.61%.

Analyst Upgrades and Downgrades

CHE has been the subject of a number of research reports. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a report on Saturday, May 4th. Royal Bank of Canada decreased their target price on Chemed from $712.00 to $697.00 and set an “outperform” rating for the company in a report on Tuesday, May 21st.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.